John Dwyer

1.3k total citations
21 papers, 418 citations indexed

About

John Dwyer is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, John Dwyer has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Economics and Econometrics. Recurrent topics in John Dwyer's work include Dementia and Cognitive Impairment Research (5 papers), Ethics in Clinical Research (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). John Dwyer is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Ethics in Clinical Research (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). John Dwyer collaborates with scholars based in United Kingdom, United States and Switzerland. John Dwyer's co-authors include Noel W. Clarke, David P. Dearnaley, Nicholas D. James, Matthew R. Sydes, Mahesh Parmar, Malcolm D. Mason, John Anderson, Gordana Jovic, Karen Sanders and George N. Thalmann and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Applied Surface Science.

In The Last Decade

John Dwyer

21 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Dwyer United Kingdom 10 118 97 73 69 54 21 418
Matt Hutmacher United States 11 57 0.5× 155 1.6× 28 0.4× 92 1.3× 83 1.5× 15 618
Katherine Johansen Taber United States 14 173 1.5× 33 0.3× 102 1.4× 77 1.1× 23 0.4× 31 1.1k
Christine Veyrat‐Follet France 15 69 0.6× 129 1.3× 65 0.9× 26 0.4× 16 0.3× 31 673
Alar Irs Estonia 8 85 0.7× 79 0.8× 50 0.7× 146 2.1× 15 0.3× 16 434
Wenhua Hu China 14 107 0.9× 71 0.7× 48 0.7× 19 0.3× 76 1.4× 33 738
Jacqueline Corrigan‐Curay United States 9 44 0.4× 106 1.1× 23 0.3× 148 2.1× 21 0.4× 13 616
Zhimin Yang China 11 86 0.7× 22 0.2× 52 0.7× 74 1.1× 11 0.2× 25 397
Robert Barrier United States 10 140 1.2× 14 0.1× 58 0.8× 45 0.7× 83 1.5× 20 447
Monica Fujii United States 10 73 0.6× 14 0.1× 106 1.5× 46 0.7× 51 0.9× 28 561
Jane D. Filie United States 8 56 0.5× 33 0.3× 19 0.3× 49 0.7× 30 0.6× 11 563

Countries citing papers authored by John Dwyer

Since Specialization
Citations

This map shows the geographic impact of John Dwyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Dwyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Dwyer more than expected).

Fields of papers citing papers by John Dwyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Dwyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Dwyer. The network helps show where John Dwyer may publish in the future.

Co-authorship network of co-authors of John Dwyer

This figure shows the co-authorship network connecting the top 25 collaborators of John Dwyer. A scholar is included among the top collaborators of John Dwyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Dwyer. John Dwyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dammer, Eric B., David A. Bennett, Richard C. Mohs, et al.. (2025). Plasma proteomic associations with Alzheimer’s disease endophenotypes. Nature Aging. 5(10). 2104–2124. 1 indexed citations
2.
Aisen, Paul, Randall J. Bateman, Damian C. Crowther, et al.. (2024). The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence. Alzheimer s & Dementia. 21(1). e14342–e14342. 9 indexed citations
3.
4.
5.
6.
Dwyer, John, et al.. (2021). Global Alzheimer’s Platform Foundation® (GAP) development of a transatlantic Alzheimer’s disease clinical trial network. Alzheimer s & Dementia. 17(S9). 1 indexed citations
7.
Dwyer, John, et al.. (2020). Orf virus infection after Eid al-Adha. IDCases. 21. e00854–e00854. 12 indexed citations
8.
Perales‐Puchalt, Jaime, Ashley R. Shaw, Ladson Hinton, et al.. (2019). Preliminary Efficacy of a Recruitment Educational Strategy on Alzheimer’s Disease Knowledge, Research Participation Attitudes, and Enrollment Among Hispanics. Hispanic Health Care International. 18(3). 144–149. 12 indexed citations
9.
Dwyer, John, et al.. (2017). Haemophilus parainfluenzae Endocarditis Associated With Maxillary Sinusitis and Complicated by Cerebral Emboli in a Young Man. Journal of Investigative Medicine High Impact Case Reports. 5(2). 2734169155–2734169155. 3 indexed citations
10.
Cummings, Jeffrey L., Paul Aisen, Rachelle S. Doody, et al.. (2016). RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER’S PLATFORM NETWORK. The Journal of Prevention of Alzheimer s Disease. 3(2). 1–7. 43 indexed citations
11.
Sydes, Matthew R., Mahesh Parmar, Malcolm D. Mason, et al.. (2012). Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial. Trials. 13(1). 168–168. 100 indexed citations
12.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. The Lancet Oncology. 13(5). 549–558. 68 indexed citations
13.
Sydes, Matthew R., Nicholas D. James, Malcolm D. Mason, et al.. (2012). Flexible trial design in practice: Dropping and adding arms in STAMPEDE (MRC PR08, CRUK/06/019)—A multiarm, multistage randomized controlled trial.. Journal of Clinical Oncology. 30(5_suppl). 27–27. 1 indexed citations
14.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from STAMPEDE (MRC PR08, CRUK/06/019), a randomized controlled trial.. Journal of Clinical Oncology. 30(5_suppl). 26–26. 3 indexed citations
15.
Sydes, Matthew R., Nicholas D. James, Malcolm D. Mason, et al.. (2011). Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial. Trials. 12(S1). 8 indexed citations
16.
James, Nicholas D., Matthew R. Sydes, M. Mason, et al.. (2011). Celecoxib Plus Hormone Therapy Vs Hormone Therapy Alone for Hormone-sensitive Prostate Cancer: First Results From the STAMPEDE Randomised Controlled Trial (MRC PR08). European Journal of Cancer. 47. 11–11. 8 indexed citations
17.
James, Nicholas D., Matthew R. Sydes, Noel W. Clarke, et al.. (2008). Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi‐arm, multistage randomized controlled trial. British Journal of Urology. 103(4). 464–469. 62 indexed citations
18.
Gazi, Ehsan, Nicholas P. Lockyer, John C. Vickerman, et al.. (2004). Imaging ToF-SIMS and synchrotron-based FT-IR microspectroscopic studies of prostate cancer cell lines. Applied Surface Science. 231-232. 452–456. 18 indexed citations
19.
Dwyer, John, et al.. (1981). Wegener's granulomatosis with otological and nervous system involvement.. PubMed. 10(6). 476–80. 9 indexed citations
20.
Dwyer, John. (1977). Maternofoetal Transmission of Immunoglobulins. The Yale Journal of Biology and Medicine. 50(6). 693–694. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matt Hutmacher Breakdown of academic impact, for papers by Katherine Johansen Taber Breakdown of academic impact, for papers by Christine Veyrat‐Follet Breakdown of academic impact, for papers by Alar Irs Breakdown of academic impact, for papers by Wenhua Hu Breakdown of academic impact, for papers by Jacqueline Corrigan‐Curay Breakdown of academic impact, for papers by Zhimin Yang Breakdown of academic impact, for papers by Robert Barrier Breakdown of academic impact, for papers by Monica Fujii Breakdown of academic impact, for papers by Jane D. Filie
Rankless by CCL
2026